Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Dambkowski Carl. Insider active across 2 companies, notably Apogee Therapeutics, Inc.. Cumulatively, 40 filings have been published. Breakdown: 0 buy · 22 sells. Total volume traded: €9.2m. History available since 3 July 2024. The latest transaction was disclosed on 5 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Dambkowski Carl
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,385 shares@ US$22.861.6% of flowCommon StockSEC:0001104659-25-096792:0
25 of 40 declarations
About Dambkowski Carl
Dambkowski Carl is a declarant associated with Apogee Therapeutics, Inc., where he is Chief Medical Officer, and with Oruka Therapeutics, Inc., where he is Director. He has 37 filings in total, and the 37 sampled filings, from 2024-07-05 to 2026-07-02, show only sales for a total of EUR 8520166.